Ally Bridge Group-WTT Global Life Science Capital Partners L.P. 13D and 13G filings for MedAvail Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-21 4:06 pm Purchase |
2023-06-16 | 13D | MedAvail Holdings, Inc. MDVL |
Ally Bridge Group-WTT Global Life Science Capital Partners L.P. | 684,752 34.300% |
136,364 (+24.87%) |
Filing |
| 2023-03-15 4:31 pm Purchase |
2023-03-13 | 13D | MedAvail Holdings, Inc. MDVL |
Ally Bridge Group-WTT Global Life Science Capital Partners L.P. | 548,389 29.600% |
136,364 (+33.10%) |
Filing |
| 2022-04-06 4:30 pm Purchase |
2022-04-04 | 13D | MedAvail Holdings, Inc. MDVL |
Ally Bridge Group-WTT Global Life Science Capital Partners L.P. | 412,025 27.100% |
336,383 (+444.71%) |
Filing |
| 2020-11-30 4:31 pm Purchase |
2020-11-18 | 13D | MedAvail Holdings, Inc. MDVL |
Ally Bridge Group-WTT Global Life Science Capital Partners L.P. | 75,642 11.900% |
75,642 (New Position) |
Filing |